Bridging Sunitinib Exposure to Time-to-Tumor Progression in Hepatocellular Carcinoma Patients With Mathematical Modeling of an Angiogenic Biomarker
利用血管生成生物标志物的数学模型，将舒尼替尼暴露与肝细胞癌患者肿瘤进展时间联系起来
期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.12084
Ait-Oudhia, S; Mager, D E; Pokuri, V; Tomaszewski, G; Groman, A; Zagst, P; Fetterly, G; Iyer, R
